CYP3A5 Genotype is Associated with Diagnosis of Hypertension in Elderly Patients: Data from the DEBATE Study

Authors: Kivistö, Kari T.1; Niemi, Mikko; Schaeffeler, Elke1; Pitkälä, Kaisu2; Tilvis, Reijo2; Fromm, Martin F.; Schwab, Matthias1; Lang, Florian3; Eichelbaum, Michel1; Strandberg, Timo2

Source: American Journal of PharmacoGenomics, Volume 5, Number 3, 2005 , pp. 191-195(5)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objective: The aim of this study was to address the presently controversial question of whether cytochrome P450 (CYP) 3A5 polymorphism is associated with hypertension.

Method: We studied 373 elderly (age ge75 years) Finnish (Caucasian) patients from the ongoing DEBATE (Drugs and Evidence Based Medicine in the Elderly) trial. The patients were classified into those with a history of hypertension (n = 229) and those without a history of hypertension (n = 144) on the basis of a detailed questionnaire on each patient’s medical history and an interview. The patients were genotyped for the CYP3A5 6986A/G single nucleotide polymorphism (SNP) [CYP3A5*1/*3 alleles].

Results: The proportion of individuals with the CYP3A5*1/*3 genotype, i.e. CYP3A5 expressors, was significantly higher among patients with a diagnosis of hypertension than among patients without (18.3% vs 9.0%, p = 0.016). The corresponding odds ratio was 2.26 (95% CI 1.17, 4.38). The allele and genotype frequencies for the two control SNPs, ABCB1 (MDR1) 3435C/T and SLCO1B1 521T/C, did not differ between the two groups.

Conclusion: This work lends support to the theory that the polymorphic CYP3A5 enzyme may be involved in regulation of blood pressure. The possible role of CYP3A5 as a genetic contributor to hypertension susceptibility warrants further study.

Keywords: Hypertension; Genetic polymorphism; Cytochrome P450; Elderly

Document Type: Research article

Affiliations: 1: 1 Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany 2: 3 Department of Medicine, Geriatric Clinic, University of Helsinki, Helsinki, Finland 3: 5 Department of Physiology, University of Tübingen, Tübingen, Germany

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$57.95 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A